Codon 72 polymorphism of p53 and its association with cervical cancer

Lancet

Volumn 354, Issue 9174, 1999, Pages 218-219

  Zehbe, Ingeborg ^a   Voglino, Gianfranco ^b   Wilander, Erik ^c   Genta, Franco ^b   Tommasino, Massimo ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b I 10126   (Italy)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CODON; DNA POLYMORPHISM; FEMALE; HUMAN; ITALY; PRIORITY JOURNAL; SWEDEN; UTERINE CERVIX CANCER; WART VIRUS;

EID: 0033578196     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)01914-5     Document Type: Article

References (5)

1. Storey A., Thomas M., Kalita A.et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 393:1998;229-234.
2. Rosenthal A.N., Ryan A., Al-Jehani R.M.et al. p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet. 352:1998;871-875.
3. Lanham S., Campbell I., Watt P., Gornall R. p53 polymorphism and risk of cervical cancer. Lancet. 352:1998;1631.
4. Hayes V.M., Hofstra R.M.W., Buys C.H.C.M.et al. Homozygous arginine-72 in wild type p53 and risk of cervical cancer. Lancet. 352:1998;1756.
5. Josefsson A.M., Magnusson P.K.E., Ylitalo N.et al. p53 polymorphism and risk of cervical cancer. Nature. 396:1998;531.